drugset / Trial / NCT05081518

A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

NCT05081518 ↗

Phase 1 Terminated 1 enrolled H. Lundbeck A/S
RandomizedCrossoverDouble-blindTreatment

Summary

The main purpose of this study is to investigate effects of Lu AG06466 on seizure activity after increasing daily doses during 4 weeks in participants with an implanted responsive neurostimulation system.

Timeline

Start
2021-09-29
Primary completion
2022-04-14
Completion
2022-04-14

Outcome

Outcome not reported

Stopped: “The study was terminated due to enrolment challenges”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown — —

Indications